DEA Moves To Ban ‘Fake Marijuana’ Products
Well, if nothing else, the United States Drug Enforcement Administration is predictable.
DEA says it will make ‘fake pot’ products illegal
via The Fort Worth Star Telegram
[excerpt] Within 30 days, the U.S. Drug Enforcement Administration will criminalize the possession and sale of “fake pot” products and the chemicals they contain for at least a year while it considers whether to ban them permanently.
The DEA announced Wednesday that it will temporarily control five chemicals used in products such as “K2″ and “Spice,” as well as the products themselves, according to a press release from the agency.
In 30 days the agency will publish a final notice making the products illegal for at least one year, with the possibility of a six-month extension while the Department of Health and Human Services studies whether the chemicals should be permanently controlled, according to the release.
And from the DEA’s official press release: The United States Drug Enforcement Administration (DEA) is using its emergency scheduling authority to temporarily control five chemicals (JWH-018, JWH-073, JWH-200, CP-47,497, and cannabicyclohexanol) used to make “fake pot” products. Except as authorized by law, this action will make possessing and selling these chemicals or the products that contain them illegal in the U.S. for at least one year while the DEA and the United States Department of Health and Human Services (DHHS) further study whether these chemicals and products should be permanently controlled.
To date, NORML officially has had little to say regarding this matter. The issue is somewhat removed from NORML’s mission statement — as the organization supports regulations for the adult use, production, and distribution of marijuana — not the retail sale and recreational use of synthetic cannabinoid agonists, which is what these chemicals are.
That said, the growing popularity of products are a predictable outgrowth of criminal marijuana prohibition. As prohibition is apt to do, it has driven the production of a commodity into the hands of unregulated, unknown dealers, driven up the potency of the commodity, and in doing so created a scenario where the consumer is faced with a potentially greater health risks than they would be had they simply had the legal choice to use the product they actually desired, in this case cannabis.
Given that most manufacturers of these products are overseas and not subject to U.S. laws and regulations, it is unlikely that the DEA’s action will in any way halt the dissemination, use, or misuse of these products by the public. Most likely, the DEA’s clamp down will likely only make the situation more dangerous — from both a legal standpoint and from a health standpoint — to the consumer.
I guess the DEA just never learns.
Ryan Grim at Huffington Post has more on the story here. November 24, 2010